These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4669329)

  • 1. Early determination of serum fibrin-fibrinogen degradation products in an intensive care unit.
    Mussche M; Baele G; Vermeire P; Barbier F; Pannier R
    Acta Clin Belg; 1972; 27(1):442-6. PubMed ID: 4669329
    [No Abstract]   [Full Text] [Related]  

  • 2. [Significance of central venous pressure--experiences of an internal medicine intensive care unit].
    Fleischmann J; Köhler H; Engelmann L
    Z Gesamte Inn Med; 1972 Mar; 27(5):202-7. PubMed ID: 5049354
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma glycerol in acute myocardial infarction.
    Wahal PK; Chauhan SP; Mehrotra MP; Gupta MC; Hazra DK; Jain VK; Maheshwari BB
    Indian Heart J; 1980; 32(3):163-8. PubMed ID: 7409845
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical significance of venous pressure].
    König E
    Med Klin; 1971 Nov; 66(46):1553-7. PubMed ID: 5138067
    [No Abstract]   [Full Text] [Related]  

  • 5. [Content of fibrinogen degradation products, soluble fibrin and the fibrinolytic activity of blood in myocardial infarct].
    Belousov IuB; Panchenko EP; Pivovarov VA; Nemiro VK
    Kardiologiia; 1979 Aug; 19(8):87-91. PubMed ID: 491364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrin degradation products and the 125I-labeled fibrinogen test in patients with myocardial infarction.
    Morris GK; Hayes MJ; Hampton JR
    Eur J Cardiol; 1974 Aug; 2(1):35-8. PubMed ID: 4472114
    [No Abstract]   [Full Text] [Related]  

  • 7. Arterial oxygen and carbon-dioxide tension in patients with acute myocardial infarction.
    Helmers C; Hofvendahl S; Lundman T; Mogensen L; Nyquist O; Säwe U; Wester P
    Cardiology; 1973; 58(6):335-46. PubMed ID: 4803002
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased plasma concentration of cross-linked fibrin polymers in acute myocardial infarction.
    Francis CW; Connaghan DG; Scott WL; Marder VJ
    Circulation; 1987 Jun; 75(6):1170-7. PubMed ID: 3568326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of fibrin degradation products during fibrinolytic therapy for acute myocardial infarction.
    Francis CW; Connaghan DG; Marder VJ
    Circulation; 1986 Nov; 74(5):1027-36. PubMed ID: 3533310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels of soluble fibrin monomer complexes in the course of myocardial infarction.
    Nowak A; Lipiński B; Drzewiecki J
    Br Heart J; 1972 Jun; 34(6):593-6. PubMed ID: 5040258
    [No Abstract]   [Full Text] [Related]  

  • 11. [The significance of changes in fibrinogen levels during thrombolytic therapy in myocardial infarct].
    Malý J; Pecka M; Pidrman V; Hamet A; Gregor J; Vodicka L; Siroký O; Tichý M
    Vnitr Lek; 1991 Mar; 37(3):229-37. PubMed ID: 2031311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanical and electric failure in myocardial infarct. Their physiopathology and treatment].
    Chávez-Rivera I
    Gac Med Mex; 1971 Apr; 101(4):369-419. PubMed ID: 5091177
    [No Abstract]   [Full Text] [Related]  

  • 13. [Changes in the content of fibrinogen and its high-molecular derivatives as affected by the physical training of ischemic heart disease patients].
    Dudaev VA; Diukov IV; Borodkin VV
    Ter Arkh; 1986; 58(12):62-7. PubMed ID: 3824217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood lactate is a predictor of short-term mortality in patients with myocardial infarction complicated by heart failure but without cardiogenic shock.
    Gjesdal G; Braun OÖ; Smith JG; Scherstén F; Tydén P
    BMC Cardiovasc Disord; 2018 Jan; 18(1):8. PubMed ID: 29347907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Place of hyperbaric oxygen in intensive care.
    Thurston JG
    Proc R Soc Med; 1971 Dec; 64(12):1287-8. PubMed ID: 5131291
    [No Abstract]   [Full Text] [Related]  

  • 16. [Alterations of plasma plasminogen and fibrinogen, serum fibrin degradation products and degree of ADP induced platelet aggregation in acute myocardial infarction (author's transl)].
    Zhonghua Xin Xue Guan Bing Za Zhi; 1979; 7(1):49-52. PubMed ID: 550980
    [No Abstract]   [Full Text] [Related]  

  • 17. [Atrial natriuretic factor in physiological conditions and pathological states].
    Fontana F; Bernardi P; Puddu P; Lenzi S
    Clin Ter; 1990 Sep; 134(6):371-82. PubMed ID: 2149534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Functional state of the thrombocytes and blood coagulation in patients with myocardial infarct complicated by shock].
    Liusov VA; Belousov IuB
    Kardiologiia; 1970 Jul; 10(7):50-9. PubMed ID: 5491671
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma concentrations of interleukin-6, organ failure, vasopressor support, and successful coronary revascularization in predicting 30-day mortality of patients with cardiogenic shock complicating acute myocardial infarction.
    Geppert A; Dorninger A; Delle-Karth G; Zorn G; Heinz G; Huber K
    Crit Care Med; 2006 Aug; 34(8):2035-42. PubMed ID: 16775569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of complications of myocardial infarction on plasma levels of prostaglandins E1 and F2 alpha].
    Miturzyńska-Stryjecka H
    Pol Tyg Lek; 1987 May; 42(21):655-7. PubMed ID: 3478659
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.